A Study of AL102 in Patients With Progressing Desmoid Tumors

Running, not enrolling · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Desmoid, Desmoid Tumor

In brief

The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.

Key facts

Study ID

NCT04871282

Run by

Immunome, Inc.

People needed

198

Starts

2021-09-01

Expected to finish

2026-12-01

Last updated by the study team

2026-06-08

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• City of Hope — Duarte, California, United States
• Sarcoma Oncology Research Center — Santa Monica, California, United States
• University of California at Los Angeles Hematology/Oncology — Santa Monica, California, United States
• Stanford University Medical Center — Stanford, California, United States
• Mayo Clinic — Jacksonville, Florida, United States
• NorthShore University Health System — Evanston, Illinois, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Jefferson City Medical Group — Jefferson City, Missouri, United States
• Washington University — St Louis, Missouri, United States
• Columbia University Irving Medical Center — New York, New York, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Levine Cancer Institute — Charlotte, North Carolina, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Ohio State University Wexner Medical Center — Columbus, Ohio, United States
• Oregon Health & Science University — Portland, Oregon, United States
• Jefferson University Hospital — Philadelphia, Pennsylvania, United States
• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
• University of Pittsburgh Medical Center, Hillman Cancer Center — Pittsburgh, Pennsylvania, United States
• UTSW Simmons Cancer Center — Dallas, Texas, United States
• MD Anderson Cancer Center — Houston, Texas, United States
• Fred Hutchinson Cancer Center — Seattle, Washington, United States
• Chris O'Brien Lifehouse — Camperdown, New South Wales, Australia
• Princess Alexandra Hospital — Woolloongabba, Queensland, Australia
• Mayo Clinic — Pheonix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.